Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines: Atrial Fibrillation Registry.
2021
Background - Antiarrhythmic drug (AAD) therapy for atrial fibrillation (AF) can be associated with both proarrhythmic and noncardiovascular toxicities. Practice guidelines recommend tailored AAD th...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
18
References
3
Citations
NaN
KQI